Illumina, Inc. (NASDAQ:ILMN) today introduced BaseSpace Apps, a
dedicated applications store for BaseSpace, the Company’s genomics cloud
computing platform. Informatics solutions available through BaseSpace
Apps will allow customers to connect with a growing community of
academic, commercial and open source tool providers who are building
applications around Illumina data to dramatically simplify and
accelerate genomic data analysis.
BaseSpace Apps will include a publicly available API (application
programming interface) that allows developers to create and deploy new
applications for the analysis of genetic data generated on Illumina
systems. Diagnomics, GenoLogics Life Sciences, Genomatix, Golden Helix,
Ingenuity Systems, Knome, Omicia, Spiral Genetics, Omixon, Real Time
Genomics, Station X, Integromics Inc., Biomax Informatics AG, and Strand
Life Sciences were named as initial application development partners.
“The rapid adoption of BaseSpace coupled with BaseSpace Apps will help
us achieve our goal to create an ecosystem where users of Illumina next
generation sequencers can easily access a broad range of genome analysis
tools from the world’s leading bioinformatics vendors,” said Alex
Dickinson, Illumina’s Senior Vice President, Cloud Genomics. “By
providing an open API and collaborative environment, we can encourage
more rapid proliferation of the tools that will enable scientists to
analyze, understand and make use of massive amounts of genetic data.”
Illumina also introduced its iSAAC genome alignment tool today.
Historically, alignment has been the most time consuming and
processor-intensive step in genome analysis. Available on BaseSpace as
well as standard workstations, iSAAC maps sequencing reads to their
proper location up to 10 times faster than existing aligners,
significantly expediting and simplifying a critical component in data
analysis.
Through BaseSpace Apps, a diverse array of new data analysis
applications and programs such as iSAAC will be available as part of a
growing toolset within the BaseSpace cloud for MiSeq® and HiSeq®
systems. Collectively, the tools will provide a wide range of
functionality, from workflow management and downstream data analysis, to
data visualization and biological interpretation.
BaseSpace is a scalable cloud-computing environment for all of
Illumina’s sequencing systems that can be accessed securely from
anywhere in the world. MiSeq system data already can be seamlessly
transferred to BaseSpace for storage, analysis and sharing between
researchers and their peers around the world, all in a secure and
user-friendly environment. HiSeq data storage and analysis capabilities
will be commercially released later this year.
About Illumina
Illumina (www.illumina.com)
is a leading developer, manufacturer, and marketer of life science tools
and integrated systems for the analysis of genetic variation and
function. We provide innovative sequencing and array-based solutions for
genotyping, copy number variation analysis, methylation studies, gene
expression profiling, and low-multiplex analysis of DNA, RNA, and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products
accelerate genetic analysis research and its application, paving the way
for molecular medicine and ultimately transforming healthcare.
Forward-Looking Statements
This release contains forward looking statements that involve risks and
uncertainties. Examples of forward-looking statements include, but are
not limited to, statements we make regarding the expected availability
dates for BaseSpace Apps and related data analysis applications and
programs. Important factors that could cause actual results to differ
materially from those in any forward-looking statements include
challenges inherent in developing and launching new products and
services and the other factors that are detailed in our filings with the
Securities and Exchange Commission, including our most recent filings on
Forms 10-K and 10-Q, or in information disclosed in public conference
calls, the date and time of which are released beforehand. We do not
intend to update any forward-looking statements after the date of this
release.
